Abstract
More than six decades have elapsed since the introduction of corticosteroids into the pharmacologic armamentarium of pediatricians. Despite the widespread clinical use of these agents for many years, several questions remain concerning their appropriate therapeutic role, indications, possible regimens, and adverse effects. The discovery of corticosteroids can be considered one of the most important therapeutic revolutions of the last century. Steroids became crucial for the treatment of several inflammatory and rheumatic diseases, including diseases that occur during childhood. However, the great enthusiasm over the discovery of corticosteroids was hampered in later years by the identification of important side effects that raised concerns regarding steroid therapy. Thus, in the past years, research focused on the development of new steroid compounds with lower toxicity and higher efficacy as well as on novel therapeutic regimens. Now, 60 years later, treatment with corticosteroids has stood the test of time, and despite the well-known side effects they are still a keystone in the therapy of many disorders and can sometimes be life-saving.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Lundberg IE, Grundtman C, Larsson E, Klareskog L (2004) Corticosteroids–from an idea to clinical use. Best Pract Res Clin Rheumatol 18:7–19
Benedek TG (2011) History of the development of corticosteroid therapy. Clin Exp Rheumatol 29(5 Suppl):S-5–S-12
Chast F (2013) History of corticotherapy. Rev Med Interne 34:258–263
Raju TN (1999) The Nobel chronicles. 1950: Edward Calvin Kendall (1886–1972); Philip Showalter Hench (1896–1965); and Tadeus Reichstein (1897–1996). Lancet 353:1370
Wolman B (1951) The use of oral cortisone in paediatrics. Br Med J 2:1246–1250
McCall MF, Ross A, Wolman B, Burns AD, Harpur EM, Goldbloom A (1952) The nephrotic syndrome in children treated with ACTH and cortisone. Arch Dis Child 27:309–321
Hench PS, Kendall EC, Slocumb CH, Polley HF (1949) The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone: compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. Proc Staff Meet Mayo Clin 24:181–197
Spirer Z, Hauser GJ (1985) Corticosteroid therapy in pediatric practice. Adv Pediatr 32:549–587
Hollander JL, Brown EM, Jessar RA, Brown CY (1951) Comparative effects of use of hydrocortisone as a local anti-arthritic agent. JAMA 147:1629–1635
Pekarek B, Osher L, Buck S, Bowen M (2011) Intra-articular corticosteroid injections: a critical literature review with up-to-date findings. Foot (Edinb) 21:66–70
Buehring B, Viswanathan R, Binkley N, Busse W (2013) Glucocorticoid-induced osteoporosis: an update on effects and management. J Allergy Clin Immunol 132:1019–1030
Wolthers OD, Pedersen S (1990) Short term linear growth in asthmatic children during treatment with prednisolone. BMJ 301:145–148
Allen DB, Mullen M, Mullen B (1994) A meta-analysis of the effect of oral and inhaled corticosteroids on growth. J Allergy Clin Immunol 93:967–976
Pope E, Krafchik BR, Macarthur C, Stempak D, Stephens D, Weinstein M, Ho N, Baruchel S (2007) Oral versus high-dose pulse corticosteroids for problematic infantile hemangiomas: a randomized, controlled trial. Pediatrics 119:e1239–e1247
Covar RA, Leung DY, McCormick D, Steelman J, Zeitler P, Spahn JD (2000) Risk factors associated with glucocorticoid-induced adverse effects in children with severe asthma. J Allergy Clin Immunol 106:651–659
Walton J, Ney RL (1975) Current concepts of corticosteroids – uses and abuses. Dis Mon Jun:3–35
Brouwer MC, McIntyre P, Prasad K, van de Beek D (2013) Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev 6:CD004405
Zalmanovici Trestioreanu A, Yaphe J (2013) Intranasal steroids for acute sinusitis. Cochrane Database Syst Rev 12:CD005149
Fernandes RM, Bialy LM, Vandermeer B, Tjosvold L, Plint AC, Patel H, Johnson DW, Klassen TP, Hartling L (2013) Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev 6:CD004878
Kramer S, Rottier BL, Scholten RJ, Boluyt N (2013) Ciclesonide versus other inhaled corticosteroids for chronic asthma in children. Cochrane Database Syst Rev 2:CD010352
Cates CJ, Karner C (2013) Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and children. Cochrane Database Syst Rev 4:CD007313
Kew KM, Karner C, Mindus SM, Ferrara G (2013) Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children. Cochrane Database Syst Rev 12:CD009019
Chauhan BF, Chartrand C, Ducharme FM (2013) Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults. Cochrane Database Syst Rev 2:CD009611
Goyal V, Chang AB (2014) Combination inhaled corticosteroids and long-acting beta2-agonists for children and adults with bronchiectasis. Cochrane Database Syst Rev 6:CD010327
Doyle LW, Ehrenkranz RA, Halliday HL (2014) Early (<8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev 5:CD001146
Doyle LW, Ehrenkranz RA, Halliday HL (2014) Late (>7 days) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database Syst Rev 5:CD001145
Anderson-James S, Marchant JM, Acworth JP, Turner C, Chang AB (2013) Inhaled corticosteroids for subacute cough in children. Cochrane Database Syst Rev 2:CD008888
Kuenzig ME, Rezaie A, Seow CH, Otley AR, Steinhart AH, Griffiths AM, Kaplan GG, Benchimol EI (2014) Budesonide for maintenance of remission in Crohn’s disease. Cochrane Database Syst Rev 8:CD002913
Cheng K, Ashby D, Smyth RL (2013) Oral steroids for long-term use in cystic fibrosis. Cochrane Database Syst Rev 6:CD000407
Beer H, Southern KW, Swift AC (2013) Topical nasal steroids for treating nasal polyposis in people with cystic fibrosis. Cochrane Database Syst Rev 4:CD008253
Syed MI, Suller S, Browning GG, Akeroyd MA (2013) Interventions for the prevention of postoperative ear discharge after insertion of ventilation tubes (grommets) in children. Cochrane Database Syst Rev 4:CD008512
Brownfoot FC, Gagliardi DI, Bain E, Middleton P, Crowther CA (2013) Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 8:CD006764
Crowther CA, Alfirevic Z, Han S, Haslam RR (2013) Thyrotropin-releasing hormone added to corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease. Cochrane Database Syst Rev 11:CD000019
Chen HS, Wang W, Wu SN, Liu JP (2013) Corticosteroids for viral myocarditis. Cochrane Database Syst Rev 10:CD004471
Stoll ML, Cron RQ (2014) Treatment of juvenile idiopathic arthritis: a revolution in care. Pediatr Rheumatol Online J 12:13
Beukelman T, Patkar NM, Saag KG, Tolleson-Rinehart S, Cron RQ, DeWitt EM, Ilowite NT, Kimura Y, Laxer RM, Lovell DJ, Martini A, Rabinovich CE, Ruperto N (2011) 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res (Hoboken) 63:465–482
Eleftheriou D, Levin M, Shingadia D, Tulloh R, Klein NJ, Brogan PA (2014) Management of Kawasaki disease. Arch Dis Child 99:74–83
Vigo G, Zulian F (2012) Periodic fevers with aphthous stomatitis, pharyngitis, and adenitis (PFAPA). Autoimmun Rev 12:52–55
Stone JH, Zen Y, Deshpande V (2012) IgG4-related disease. N Engl J Med 366:539–551
Husebye ES, Allolio B, Arlt W, Badenhoop K, Bensing S, Betterle C, Falorni A, Gan EH, Hulting AL, Kasperlik-Zaluska A, Kämpe O, Løvås K, Meyer G, Pearce SH (2014) Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency. J Intern Med 275:104–115
Hoes JN, Jacobs JW, Boers M, Boumpas D, Buttgereit F, Caeyers N, Choy EH, Cutolo M, Da Silva JA, Esselens G, Guillevin L, Hafstrom I, Kirwan JR, Rovensky J, Russell A, Saag KG, Svensson B, Westhovens R, Zeidler H, Bijlsma JW (2007) EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases. Ann Rheum Dis 66:1560–1567
van der Goes MC, Jacobs JW, Boers M, Andrews T, Blom-Bakkers MA, Buttgereit F, Caeyers N, Cutolo M, Da Silva JA, Guillevin L, Kirwan JR, Rovensky J, Severijns G, Webber S, Westhovens R, Bijlsma JW (2010) Monitoring adverse events of low-dose glucocorticoid therapy: EULAR recommendations for clinical trials and daily practice. Ann Rheum Dis 69:1913–1919
Duru N, van der Goes MC, Jacobs JW, Andrews T, Boers M, Buttgereit F, Caeyers N, Cutolo M, Halliday S, Da Silva JA, Kirwan JR, Ray D, Rovensky J, Severijns G, Westhovens R, Bijlsma JW (2013) EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases. Ann Rheum Dis 72:1905–1913
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Saggese, G., Vierucci, F. (2015). Systemic Corticosteroids for Autoimmune/Inflammatory Disorders in Children: Introduction. In: Cimaz, R. (eds) Systemic Corticosteroids for Inflammatory Disorders in Pediatrics. Adis, Cham. https://doi.org/10.1007/978-3-319-16056-6_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-16056-6_1
Publisher Name: Adis, Cham
Print ISBN: 978-3-319-16055-9
Online ISBN: 978-3-319-16056-6
eBook Packages: MedicineMedicine (R0)